The association of hyperglycaemia and insulin resistance with incident depressive symptoms over 4 years of follow-up: The Maastricht Study
Year: 2020
Type: article
Study design: Observational Study
Abstract: Aims/hypothesis Depression is twice as common in individuals with type 2 diabetes as in the general population. However, it remains unclear whether hyperglycaemia and insulin resistance are directly involved in the aetiology of depression. Therefore, we investigated the association of markers of hyperglycaemia and insulin resistance, measured as continuous variables, with incident depressive symptoms over 4 years of follow-up. Methods We used data from the longitudinal population-based Maastricht Study (n = 2848; mean age 59.9 ± 8.1 years, 48.8% women, 265 incident depression cases, 10,932 person-years of follow-up). We assessed hyperglycaemia by fasting and 2 h post-load OGTT glucose levels, HbA1c and skin autofluorescence (reflecting AGEs) at baseline. We used the Matsuda insulin sensitivity index and HOMA-IR to calculate insulin resistance at baseline. Depressive symptoms (nine-item Patient Health Questionnaire score ≥10) were assessed at baseline and annually over 4 years. We used Cox regression analyses, and adjusted for demographic, cardiovascular and lifestyle risk factors. Results Fasting plasma glucose, 2 h post-load glucose and HbA1c levels were associated with an increased risk for incident depressive symptoms after full adjustment (HR 1.20 [95% CI 1.08, 1.33]; HR 1.25 [1.08, 1.44]; and HR 1.22 [1.09, 1.37] per SD, respectively), while skin autofluorescence, insulin sensitivity index and HOMA-IR were not (HR 0.99 [0.86, 1.13]; HR 1.02 [0.85, 1.25]; and HR 0.93 [0.81, 1.08], per SD, respectively). Conclusions/interpretation The observed temporal association between hyperglycaemia and incident depressive symptoms in this study supports the presence of a mechanistic link between hyperglycaemia and the development of depressive symptoms.
Source: Diabetologia
Authors: Anouk F. J. Geraets, Sebastian Köhler, Rutendo Muzambi, Casper G. Schalkwijk, Anke Oenema, Simone J. P. M. Eussen, Pieter C. Dagnelie, Coen D. A. Stehouwer, Nicolaas C. Schaper, Ronald M. A. Henry, Carla J. H. van der Kallen, Anke Wesselius, Annemarie Koster, Frans R. J. Verhey, Miranda T. Schram
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,480
Funders: Sanofi, Health Foundation Limburg, Novo Nordisk, Maastricht Universitair Medisch Centrum, Stichting De Weijerhorst, European Regional Development Fund, CARIM School for Cardiovascular Diseases, Universiteit Maastricht, Care and Public Health Research Institute, Universiteit Maastricht, NUTRIM School of Nutrition and Translational Research in Metabolism, Cilag
Awards: G3036254274, G8738466114
OpenAlex ID: W3047077792
